18 November 2004
Oxford Diffraction Raises Expansion Funding.
11 September 2004
Universität zu Lübeck to use an Oxford Diffraction Xcalibur PX Ultra system for Crystal Structural Studies of SARS Virus Proteins
26 August 2004
Oxford Diffraction launches GEMINI – the complete service diffractometer – at ECM22
12 July 2004
24 June 2004
The Structural Genomics Consortium in Oxford becomes a protein crystallography reference site for Oxford Diffraction
1 November 2003
Oxford Diffraction relocate to new premises
22 May 2003
Oxford Diffraction Launch Platinum Level US Reference Site for Crystallography at Virginia Tech
15 September 2003
Johann Wolfgang Goethe-Universität, Frankfurt, becomes German reference site for Oxford Diffraction
21 January 2003
Oxford Diffraction Limited Announce Collaboration with York Structural Biology Laboratory to Evaluate New Protein Crystallography X-ray Diffractometer
11 October 2002
Oxford Diffraction Launch Gold Level US Reference Site for Crystallography at Virginia Tech
12 November 2002
Swiss Norwegian Beamline Purchase New Large Area CCD Detector for Six-Circle Synchrotron Diffractometer from Oxford Diffraction Limited
10 September 2002
Oxford Diffraction launches Xcalibur PX – a compact and cost-effective
macromolecular crystallography system
7 March 2002
Crystal Cooling to <15 Kelvin : Oxford Diffraction's Helijet put through its
paces at the ESRF, Europe's leading Synchrotron
30 March 2001
Venture Funding for Oxfordshire spin-out to uncover the structure of molecules and proteins
|
 |
24 June 2004
The Structural Genomics Consortium in Oxford becomes a protein crystallography reference site for Oxford DiffractionThe Structural Genomics Consortium (SGC) in Oxford, UK, has agreed to become the local reference site for Oxford Diffraction Limited for its novel Xcalibur PX Ultra protein crystallography product.The SGC in Oxford purchased Xcalibur PX Ultra in February 2004 as a convenient way to screen crystals generated in their high-throughput laboratory. Since its installation in March 2004, Xcalibur PX Ultra has been put through its paces on a variety of protein systems and directly compared to a 5kW rotating anode. From Oxford Diffraction, Dr. Paul Loeffen, CEO, said “We are delighted that a high profile and important institute as the SGC have recognised the unique advantages of Xcalibur PX Ultra as a tool that will contribute to the achievement of their ambitious goals. We look forward to working closely with them in the future as one of our key reference sites”. The SGC is a not-for-profit organization that aims to determine the three dimensional structures of proteins of medical relevance, and place them in the public domain without restriction. Announced in April 2003, this initiative receives funding from Canadian and British sponsors, from both the public and private sectors - the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Ontario Research and Development Challenge Fund, the Ontario Innovation Trust and the Canadian Institutes of Health Research. The goal of this undertaking is to develop the infrastructure and technologies necessary for rapid, parallel, structure determination, with the aim of having the capability to determine 200 protein structures per year. Over the first four years, the SGC will target 350 proteins that have relevance to human health and disease, such as proteins associated with diabetes, cancer, and infectious disease such as malaria. Targets will also be chosen based on interest from the scientific community, the pharmaceutical industry, expertise within the Consortium and scientific impact. |
 |
 |
 |
Copyright © 2009 Oxford Diffraction, all rights reserved
UK company registered number: 4020656
